Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3545311

BRIGATINIB
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1

Basic Information

ChEMBL ID CHEMBL3545311
Name BRIGATINIB
Phase Approved
Structure Type MOL
InChI Key AILRADAXUVEEIR-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Alunbrig Ap-26113 AP26113 Brigatinib
93
Targets
349
Activities
2
Assay Types
22
PK Parameters
20
Publications
4
Known Names
5
Indications
2
Mechanisms

Molecular Properties

584.1
MW (Da)
5.09
ALogP
9
HBA
2
HBD
85.9
PSA (Ų)
0.35
QED
2
Ro5 Violations
8
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2017
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Natural Product
USAN Stem -tinib
USAN Year 2014

Extended Properties

Molecular Formula C29H39ClN7O2P
MW 584.11
Aromatic Rings 3
Heavy Atoms 40
NP-Likeness -1.32

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
ALK tyrosine kinase receptor inhibitor INHIBITOR ALK tyrosine kinase receptor
Epidermal growth factor receptor erbB1 inhibitor INHIBITOR Epidermal growth factor receptor

Indications

Carcinoma, Non-Small-Cell Lung Neoplasms Carcinoma Lung Neoplasms Lymphoma, Large-Cell, Anaplastic

ATC Classification

L01ED04
brigatinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS

Activity Summary

IC50 347 meas. best 10.19
EC50 2 meas. best 6.53

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
BaF3
CHEMBL614524
IC50 10.19 7.119 0.1 41
ALK tyrosine kinase receptor
CHEMBL4247
IC50 9.43 8.616 0.4 20
Epidermal growth factor receptor
CHEMBL203
IC50 9.15 7.7004 0.7 74
Tyrosine-protein kinase Fer
CHEMBL3982
IC50 8.89 8.89 1.3 1
A-431
CHEMBL614069
IC50 8.87 6.6717 1.4 6
PC-9
CHEMBL614102
IC50 8.84 6.6655 1.5 11
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
IC50 8.82 7.4543 1.5 7
SR
CHEMBL614300
IC50 8.72 8.59 1.9 3
Proto-oncogene tyrosine-protein kinase ROS
CHEMBL5568
IC50 8.72 8.72 1.9 2
HCC827
CHEMBL4296422
IC50 8.52 7.6533 3.0 3
Tyrosine-protein kinase Fes/Fps
CHEMBL5455
IC50 8.46 8.46 3.5 1
Focal adhesion kinase 1
CHEMBL2695
IC50 8.41 8.41 3.9 1
Protein-tyrosine kinase 6
CHEMBL4601
IC50 8.39 8.39 4.1 1
Testis-specific serine/threonine-protein kinase 1
CHEMBL6003
IC50 8.36 8.36 4.4 1
Serine/threonine-protein kinase Chk2
CHEMBL2527
IC50 8.25 8.22 5.6 2
Unchecked
CHEMBL612545
IC50 8.25 6.7228 5.6 46
EML4-ALK
CHEMBL3883330
IC50 8.05 7.3292 9.0 25
Ribosomal protein S6 kinase alpha-2
CHEMBL3906
IC50 7.89 7.89 13.0 1
Leukocyte tyrosine kinase receptor
CHEMBL5627
IC50 7.85 7.85 14.0 1
Protein cereblon/EML4/ALK
CHEMBL4296166
IC50 7.85 7.85 14.0 1
ROS1-SDC4
CHEMBL5303568
IC50 7.8 7.8 16.0 1
CD74-ROS1
CHEMBL4680046
IC50 7.75 7.75 18.0 1
Tyrosine-protein kinase Yes
CHEMBL2073
IC50 7.72 7.72 19.0 1
Proto-oncogene tyrosine-protein kinase receptor Ret
CHEMBL2041
IC50 7.66 7.4733 22.0 3
Dual specificity protein kinase CLK1
CHEMBL4224
IC50 7.64 7.64 23.0 1
Protein-tyrosine kinase 2-beta
CHEMBL5469
IC50 7.62 7.62 24.0 1
Insulin-like growth factor 1 receptor
CHEMBL1957
IC50 7.6 7.19 24.9 3
Ribosomal protein S6 kinase alpha-3
CHEMBL2345
IC50 7.58 7.58 26.0 1
Receptor tyrosine-protein kinase erbB-4
CHEMBL3009
IC50 7.57 7.57 27.0 1
Calcium/calmodulin-dependent protein kinase type II subunit delta
CHEMBL2801
IC50 7.54 7.54 29.0 1
NON-PROTEIN TARGET
CHEMBL3879801
IC50 7.54 6.52 29.0 2
Serine/threonine-protein kinase Chk1
CHEMBL4630
IC50 7.52 7.52 30.0 1
Ribosomal protein S6 kinase alpha-1
CHEMBL2553
IC50 7.52 7.52 30.0 1
NCI-H2228
CHEMBL1075536
IC50 7.51 7.375 31.2 2
Fibroblast growth factor receptor 1
CHEMBL3650
IC50 7.39 7.14 41.0 2
Ribosomal protein S6 kinase alpha-6
CHEMBL4924
IC50 7.38 7.38 42.0 1
Receptor tyrosine-protein kinase erbB-2
CHEMBL1824
IC50 7.38 7.38 42.0 1
Insulin receptor-related protein
CHEMBL5483
IC50 7.35 7.35 45.0 1
NUAK family SNF1-like kinase 1
CHEMBL5784
IC50 7.33 7.33 47.0 2
Calcium/calmodulin-dependent protein kinase type II subunit gamma
CHEMBL3829
IC50 7.32 7.32 48.0 1
Leucine-rich repeat serine/threonine-protein kinase 2
CHEMBL1075104
IC50 7.29 7.29 51.0 1
Tyrosine-protein kinase FRK
CHEMBL4223
IC50 7.28 7.28 52.0 1
Vascular endothelial growth factor receptor 3
CHEMBL1955
IC50 7.24 7.24 58.0 1
Hepatocyte growth factor receptor
CHEMBL3717
IC50 7.16 7.16 70.0 1
Calcium/calmodulin-dependent protein kinase kinase 2
CHEMBL5284
IC50 7.09 7.09 82.0 1
Mast/stem cell growth factor receptor Kit
CHEMBL1936
IC50 7.08 6.9167 83.0 3
MAP kinase-interacting serine/threonine-protein kinase 1
CHEMBL4718
IC50 7.06 7.06 88.0 1
Serine/threonine-protein kinase MARK2
CHEMBL3831
IC50 7.03 7.03 93.0 1
Serine/threonine-protein kinase D3
CHEMBL2595
IC50 7.02 7.02 95.0 1
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
CHEMBL2349
IC50 6.97 6.97 108.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 2268.0 ng.hr.mL-1 Rattus norvegicus
AUC 3954.0 ng.hr.mL-1 Rattus norvegicus
AUC 5772.0 ng.hr.mL-1 Mus musculus
AUC 6493.0 ng.hr.mL-1 Mus musculus
AUC 6502.0 ng.hr.mL-1 Mus musculus
AUC 6493.0 ng.hr.mL-1 Mus musculus
AUC 6502.0 ng.hr.mL-1 Mus musculus
CL 7.667 mL.min-1.kg-1 Rattus norvegicus
CL 3.1 mL.min-1.g-1 Homo sapiens
Cmax 522.16 nM Rattus norvegicus
Cmax 766.98 nM Mus musculus
Cmax 1587.03 nM Mus musculus
Cmax 1587.03 nM Mus musculus
F 52.0 % Rattus norvegicus
Fu 0.155 - Homo sapiens
Fu 0.343 - Homo sapiens
T1/2 4.8 hr Rattus norvegicus
T1/2 3.4 hr Rattus norvegicus
T1/2 5.8 hr Mus musculus
T1/2 2.8 hr Mus musculus
T1/2 2.8 hr Mus musculus
Tmax 4.0 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
BaF3 IC50 = 0.065 nM 10.19 Antiproliferative activity against mouse BaF3 cells harboring EGFR C797S/Del19/T... 38908104
BaF3 IC50 = 0.071 nM 10.15 Antiproliferative activity against mouse BaF3 cells harboring EGFR C797S/L858R/T... 38908104
ALK tyrosine kinase receptor IC50 = 0.37 nM 9.43 Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]AT... 27144831
BaF3 IC50 = 0.492 nM 9.31 Antiproliferative activity against mouse BaF3 cells harboring EGFR 19 del/T790M/... 35446588
ALK tyrosine kinase receptor IC50 = 0.6 nM 9.22 Inhibition of human ALK using poly (Glu, Tyr)4:1 as substrate in presence of [ga... 27780853
ALK tyrosine kinase receptor IC50 = 0.6 nM 9.22 Inhibition of human ALK C1156Y mutant using poly (Glu, Tyr)4:1 as substrate in p... 27780853
Epidermal growth factor receptor IC50 = 0.7 nM 9.15 Inhibition of EGFR del19/T790M mutant (unknown origin) 35413415
Epidermal growth factor receptor IC50 = 0.82 nM 9.09 Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as ... 35810715
Epidermal growth factor receptor IC50 = 0.82 nM 9.09 Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin) using TK as ... 37269687
Epidermal growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGF... 31718182
BaF3 IC50 = 1.0 nM 9.0 Antiproliferative activity against crizotinib resistant mouse BaF3 cells express... 35421578
Epidermal growth factor receptor IC50 = 1.0 nM 9.0 Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGF... 31718182
ALK tyrosine kinase receptor IC50 = 1.2 nM 8.92 Binding affinity to ALK (unknown origin) 34138566
Tyrosine-protein kinase Fer IC50 = 1.3 nM 8.89 Inhibition of human FER using poly (Glu, Tyr)4:1 as substrate in presence of [ga... 27780853
Epidermal growth factor receptor IC50 = 1.3 nM 8.89 Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate ... 37197473
A-431 IC50 = 1.359 nM 8.87 Antiproliferative activity against human A-431 cells harboring wild type EGFR as... 35446588
ALK tyrosine kinase receptor IC50 = 1.4 nM 8.85 Inhibition of human ALK F1174L mutant using poly (Glu, Tyr)4:1 as substrate in p... 27780853
PC-9 IC50 = 1.454 nM 8.84 Antiproliferative activity against human osimertinib-resistant PC-9 cells harbor... 35446588
Epidermal growth factor receptor IC50 = 1.5 nM 8.82 Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA 32631532
Epidermal growth factor receptor IC50 = 1.5 nM 8.82 Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA 32631532

Literature References

PubMed DOI Target Context # Activities
27780853 10.1158/1078-0432.ccr-16-0569 EML4-ALK 113
28287083 10.1038/ncomms14768 Unchecked 55
27780853 10.1158/1078-0432.ccr-16-0569 Unchecked 51
27780853 10.1158/1078-0432.ccr-16-0569 ADMET 28
28287083 10.1038/ncomms14768 Epidermal growth factor receptor 26
27780853 10.1158/1078-0432.ccr-16-0569 ALK tyrosine kinase receptor 20
27780853 10.1158/1078-0432.ccr-16-0569 Epidermal growth factor receptor 13
35421578 10.1016/j.bmcl.2022.128730 BaF3 13
28287083 10.1038/ncomms14768 PC-9 12
37839342 10.1016/j.ejmech.2023.115865 Unchecked 10
27780853 10.1158/1078-0432.ccr-16-0569 Receptor-type tyrosine-protein kinase FLT3 10
27780853 10.1158/1078-0432.ccr-16-0569 BaF3 10
- 10.6019/CHEMBL4689842 U2OS 9
34245852 10.1016/j.bmcl.2021.128253 NCI-H2228 9
- 10.6019/CHEMBL4689842 Fibroblast 9
27144831 10.1021/acs.jmedchem.6b00306 Rattus norvegicus 9
27144831 10.1021/acs.jmedchem.6b00306 NON-PROTEIN TARGET 9
37336419 10.1016/j.bmcl.2023.129381 Unchecked 8
- 10.6019/CHEMBL4689842 HEK-293T 8
35413415 10.1016/j.bmcl.2022.128729 Epidermal growth factor receptor 8

Data from ChEMBL 36 via Core Engine